Researchers are working to overcome resistance to a type of cancer treatment known as immune checkpoint inhibitor therapy in patients with acute myeloid leukemia. The therapy has shown promise, but resistance to it is a challenge that needs to be addressed. Efforts are being made to find ways to overcome this resistance and improve treatment outcomes for acute myeloid leukemia patients.